Literature DB >> 6971529

[Antinuclear antibodies in ankylosing spondylitis (author's transl)].

E Prohaska, J Neumüller, G Partsch, R Eberl.   

Abstract

Antinuclear antibodies (ANA) were found in 19.1% of patients suffering from ankylosing spondylitis (n = 320). This figure is significantly higher than the results obtained in a control group. ANA were present in all stages of the disease, including the abortive form of isolated sacroiliitis. ANA were also found in different stages of activity. In addition, ANA-positive cases showed a higher inflammatory activity. In females ANA were more frequently found than in males. There was a positive correlation between ANA and HLA B27 in 87.2%.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6971529

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  3 in total

1.  Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.

Authors:  E Kruithof; F Van den Bosch; D Baeten; A Herssens; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 2.  Ankylosing spondylitis coexists with rheumatoid arthritis and Sjögren's syndrome: a case report with literature review.

Authors:  Guo Wang Zhao; Lin Fang Huang; Dian Li; Yan Zeng
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

3.  Isolated sacroiliitis as monosymptomatic form of ankylosing spondylitis--a possible cause of chronic back pain.

Authors:  E Prohaska
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.